Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced that management will present and participate at several events in March with investors, analysts, bankers and potential partners.
February 25, 2022
· 4 min read